Agilent Technologies Stock Forecast, Price & News

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There are currently 3 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" Agilent Technologies stock.
View analyst ratings for Agilent Technologies or view top-rated stocks.

12 Wall Street research analysts have issued 12 month price targets for Agilent Technologies' stock. Their A stock forecasts range from $130.00 to $185.00. On average, they expect Agilent Technologies' stock price to reach $159.91 in the next twelve months. This suggests a possible upside of 33.9% from the stock's current price.
View analysts' price targets for Agilent Technologies or view top-rated stocks among Wall Street analysts.

Agilent Technologies' stock was trading at $159.65 at the beginning of the year. Since then, A shares have decreased by 25.2% and is now trading at $119.43.
View the best growth stocks for 2022 here.

Agilent Technologies saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 2,880,000 shares, a decrease of 18.9% from the May 15th total of 3,550,000 shares. Based on an average daily volume of 1,970,000 shares, the short-interest ratio is currently 1.5 days. Currently, 1.0% of the company's stock are sold short.
View Agilent Technologies' Short Interest.

Agilent Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, August 16th 2022.
View our earnings forecast for Agilent Technologies.

Agilent Technologies, Inc. (NYSE:A) announced its quarterly earnings data on Tuesday, May, 24th. The medical research company reported $1.13 earnings per share for the quarter, beating analysts' consensus estimates of $1.12 by $0.01. The medical research company had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.62 billion. Agilent Technologies had a trailing twelve-month return on equity of 27.42% and a net margin of 19.35%. The business's revenue for the quarter was up 5.4% on a year-over-year basis. During the same quarter last year, the company posted $0.97 earnings per share.
View Agilent Technologies' earnings history.

Agilent Technologies declared a quarterly dividend on Wednesday, May 18th. Stockholders of record on Tuesday, July 5th will be given a dividend of $0.21 per share on Wednesday, July 27th. This represents a $0.84 annualized dividend and a dividend yield of 0.70%. The ex-dividend date is Friday, July 1st.
View Agilent Technologies' dividend history.

Agilent Technologies(NYSE:A) pays an annual dividend of $0.84 per share and currently has a dividend yield of 0.71%. Agilent Technologies has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Agilent Technologies is 20.24%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Agilent Technologies will have a dividend payout ratio of 15.56% next year. This indicates that Agilent Technologies will be able to sustain or increase its dividend.
View Agilent Technologies' dividend history.

Agilent Technologies declared that its board has initiated a stock repurchase program on Tuesday, February 16th 2021, which allows the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase up to 5% of its stock through open market purchases. Stock buyback programs are often an indication that the company's leadership believes its shares are undervalued.

Agilent Technologies issued an update on its FY 2022 earnings guidance on Tuesday, June, 21st. The company provided EPS guidance of $4.86-$4.93 for the period, compared to the consensus EPS estimate of $4.60. The company issued revenue guidance of $6.67 billion-$6.73 billion, compared to the consensus revenue estimate of $6.36 billion.

452 employees have rated Agilent Technologies CEO Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among Agilent Technologies' employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Agilent Technologies include Thermo Fisher Scientific (TMO), Illumina (ILMN), Mettler-Toledo International (MTD), Waters (WAT), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD).
View all of A's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of A stock can currently be purchased for approximately $119.43.

Agilent Technologies (NYSE:A) has a market capitalization of $35.67 billion and generates $6.32 billion in revenue each year. The medical research company earns $1.21 billion in net income (profit) each year or $4.15 on an earnings per share basis.

Agilent Technologies employs 17,000 workers across the globe.

Agilent Technologies was founded in 1999.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The official website for Agilent Technologies is www.agilent.com. The medical research company can be reached via phone at (800) 227-9770, via email at [email protected], or via fax at 408-345-8474.